Diagnostic criteria for diabetes Routine cases and Non-diabetic hyperglycaemia adapted with permission from Royal Devon and Exeter

Similar documents
NHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes

NHS Highland Diabetes Managed Clinical Network Newsletter. Welcome to this issue of the NHS Highland Diabetes MCN Newsletter. (October 2016).

GLUCOSE TOLERANCE TEST: FOR THE DIAGNOSIS OF DIABETES MELLITUS

NHS DIABETES PREVENTION PROGRAMME: Preventing Type 2 Diabetes in England

Type 2 diabetes how to prevent it? East of England Diabetes Mellitus Transformation and Sustainability Network 28 th March 2018

Diabetes Diagnosis 2011 Does your patient have diabetes?

NHS DIABETES PREVENTION PROGRAMME: Preventing Type 2 Diabetes in England

QOF Indicator DM013:

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead

Diabetes Mellitus. Eiman Ali Basheir. Mob: /1/2019

Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus

NHS NATIONAL DIABETES PREVENTION PROGRAMME. Tom Newbound, NHS DPP Programme Manager

DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for

Placename CCG. Policies for the Commissioning of Healthcare

Improving Diabetes Care

Monitoring in Type 2 Diabetes. Learning Outcomes. Type 2 Diabetes. Senga Hunter Community Diabetes Specialist Nurse

2. Evidence of continued professional development in this area on a 2 yearly basis

NICE Indicator Programme. Consultation on proposed amendments to current QOF indicators

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Diabetes. Ref HSCW 024

pat hways Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16

POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK

EFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY

Diabetes Mellitus (DM) Chronic metabolic disorder with a predisposition of hyperglycaemia (increased blood glucose).

Quality Improvement Tool Instruction Guide Diabetes Care

The Health Problem: Guidelines: NHS Priority:

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)

Diabetes Prevention programme

Tackling Diabetes Together. The Greater Manchester Diabetes Strategy ( )

Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014

The principles of insulin adjustment guidance

Diabetes in Pregnancy Network: Scoping survey March 2013

WILL YOU USE HBA1C TO SCREEN & MONITOR DIABETES? Dr. Amany Mousa

Screening, Diagnosis and Management of Gestational Diabetes in New Zealand: A Clinical Practice Guideline

Delivery of An Evolving Well Established Community Diabetes Service in South Sefton

How effective are national strategies for getting evidence into practice?

NHS Leeds CCG. Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)

NHS GG&C Introduction of Freestyle Libre flash glucose monitoring system

Diabetes education: the big missed opportunity in diabetes care? Phaedra Perry Regional Head South West Katherine Calder Senior Policy Officer

Standards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE

University of Birmingham and University of York Health Economics Consortium (NCCID) Development feedback report on piloted indicators

SERVICE SPECIFICATION 6 Conservative Management & End of Life Care

Personal statement on Continuous Subcutaneous Insulin Infusion Professor John Pickup

Networking for success: A burning platform in Berkshire West

Guideline for antihyperglycaemic therapy in adults with type 2 diabetes

Referral and Ongoing Care for Children with Suspected Diabetes

Flash Glucose Monitoring (Flash GM) Frequently asked questions (November 2018)

Shaping Diabetes Services in Southern Derbyshire. A vision for Diabetes Services For Southern Derbyshire CCG

The York Diabetes Care Model

DIABETES 20/02/2014 WHAT IS DIABETES? GLUCOSE WHAT IS DIABETES? GLUCOSE HOMEOSTASIS GLUCOSE METABOLISM

Placename CCG. Policies for the Commissioning of Healthcare

Level 4 Certificate In Physical Activity and Weight Management for Obese and Diabetic Clients

DR HJ BODANSKY MD FRCP CONSULTANT PHYSICIAN LEEDS TEACHING HOSPITALS ASSOCIATE PROFESSOR, UNIVERSITY OF LEEDS

Care Bundle. Adult patients with Type 2 Diabetes

NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. Produced by: National Cardiovascular Intelligence Network (NCVIN)

Pre-Dialysis Insulin Information for Patients with Type 2 Diabetes receiving haemodialysis

Summary of 2011/12 QOF indicator changes, points and thresholds

DIABETES STRUCTURED EDUCATION IN WORCESTERSHIRE Information for Healthcare Professionals May 2011

Referral to Adult Diabetes Specialist Services

FIT for symptomatic patients. Facilitator name

Audit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Type 2 diabetes: the management of type 2 diabetes (update)

dulaglutide 0.75mg and 1.5mg solution for injection in pre-filled pen (Trulicity ) SMC No. (1110/15) Eli Lilly and Company Ltd.

Type 2 Diabetes: Screening and Prevention. Updating the Scottish Needs Assessment Programme Report on. Recommendations

Diabetes Care Audit Instructional Guide

Dementia Programme Kevin Mullins Head of Mental Health Services

TREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse

West Midlands Familial Hypercholesterolaemia Service

Screening. Dr Helen Raison Consultant, Public Health Royal Borough of Kingston

NHS Diabetes Prevention Programme Digital Stream. Diane Powell (National Prevention Lead - Digital)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

YOU HAVE DIABETES. Angie O Connor Community Diabetes Nurse Specialist 25th September 2013

Department of Nutrition & Dietetics: Adult Outpatient Referral Criteria

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

The National Quality Standards for Chronic Kidney Disease

Dept of Diabetes Main Desk

PARTICULARS, SCHEDULE 2 THE SERVICES, A SERVICE SPECIFICATION. A03/S(HSS)/a Pancreas transplantation service (Adult)

Map 6: Percentage of people in the National Diabetes Audit (NDA) with Type 1 diabetes receiving all nine key care processes by PCT

Pre-diabetes. Dr Neel Basudev. GPSI Lambeth DICT, Diabetes Lead Lambeth CCG

Type 2 Diabetes. Stopping Smoking. Consider referral to smoking cessation. Consider referring for weight management advice.

Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus

DIABETES WITH PREGNANCY

Shared Care Guideline for Olanzapine (Zyprexa )

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

SCHEDULE 2 THE SERVICES

IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS

Medicines Optimisation Team Standard Operating procedure for Alogliptin Audit:

Physical Health Checks

CommUnityCare Women s Health Brackenridge Professional Office Building

National Diabetes Audit, Report 1: Care Processes and Treatment Targets

EXENATIDE (BYETTA ) PROTOCOL, 5mcg and 10mcg SC injection pre-filled pens

Use of Telehealth in Antenatal Diabetes clinics. Chandi Idampitiya Consultant Endocrinologist Cumbria Partnership NHS Foundation Trust

Primary Prevention Patients aged 85yrs and over

2. Quality and Outcomes Framework: new NICE recommendations

CQC Insight. NHS GP practices Indicators and methodology

Rehabilitation & Exercise. For Renal Patients

Essential Shared Care Agreement (South Staffordshire): Aciclovir Administration in the Community

Formulary and Prescribing Guidelines

Transcription:

Diagnostic criteria for diabetes Routine cases and Non-diabetic hyperglycaemia adapted with permission from Royal Devon and Exeter Diabetes may be diagnosed on any of the following criteria (WHO 2006, John 2012, NICE 2012). Diabetes NDH Normal HbA1c mmol/mol 48 and above 42-47 41 or less Fasting Plasma Glucose 7.0mmol/L and above 5.5-6.9 mmol/l 5.4 mmol/l or less 2hr Plasma Glucose in 11.1mmol/L and above 7.8-11.0 mmol/l 7.7 mmol/l or less OGTT Random Plasma Glucose 11.1mmol/L and above NDH= Non-diabetic hyperglycaemia Fasting = 8 hours or more without caloric intake (ADA 2018) A repeat confirmatory test is required in most cases, see below. Which test is best? National and international expert groups do not know. Relevant groups (WHO, ADA, UKDHADC, NICE) simply advise that HbA1c is now an option for diagnosing diabetes. Benefits to using HbA1c for diagnosis No need for patient to fast More reproducible than glucose. Continuity with diabetes (once diagnosed, we switch from glucose to Hb1A1c, so it makes sense to use HbA1c for diagnosis) Disadvantages to using HbA1c: Inappropriate for some patients (see below). We do not wish to be prescriptive. You may prefer fasting glucose, if simpler than assessing each patient s suitability for diagnosis by HbA1c. Generally we recommend HbA1c. Please choose a single test for diagnosis and if necessary repeat this test to make the diagnosis. Should a positive test be repeated? In the asymptomatic patient a repeat test is required, please repeat the same test as requested initially. National Guidance recommends a repeat test within 2 weeks of the first one. A diagnosis of Diabetes is only made is both results are at or above the diagnostic threshold.

In the patient with classical symptoms of diabetes a repeat test is not required. Patients with suspected Type 1 Diabetes should be referred urgently to local level 4 Diabetes services in line with established pathways. When not to use HbA1c to diagnose diabetes These are the most common situations where HbA1c is not suitable. Except in pregnancy, diagnose by fasting glucose 7.0 mmol/l twice, or once with symptoms. In pregnancy, follow NICE guidelines. 1. Rapid onset of diabetes -An increase in HbA1c may not be detected until a few weeks later. a. Suspected type 1 diabetes rapid onset of symptoms, weight loss, ketosis. b. Children because most will have type 1 diabetes. c. Steroids. Antipsychotics & immunosuppressant s can raise blood glucose, rarely precipitously d. After pancreatitis or pancreatic surgery. 2.Pregnancy. Multiple factors make HbA1c lower in pregnancy. The diagnosis of gestational diabetes should be made on blood glucose, in line with NICE guidance. 3.Conditions with reduced red survival may lower HbA1c: a. Haemoglobinopathy which will normally be detected by the lab, but should be suspected in racial groups where there is a high prevalence of sickle trait, sickle disease or thalassaemia. b. Haemolytic anaemia c. Severe blood loss d. Splenomegaly e. Antiretroviral drugs 4. Increased red cell survival may increase HbA1c e.g. splenectomy. 5. Renal dialysis patients have a markedly reduced HbA1c especially if treated with erythropoietin. 6. Iron and B12 deficiency and their treatment. May raise or lower HbA1c, but the effect is small.

What if you have glucose values and an HbA1c on a single patient? This is confusing, so don t get into that situation use HbA1c alone, or glucose alone. If you already have both, WHO guidance diagnoses diabetes if either result is high. With same guidance for repeat if asymptomatic. If both are above the threshold for diagnosis of diabetes then diabetes can be diagnosed at that stage. What is NDH and how should we manage it? Non-diabetic hyperglycaemia is the current NHS preferred term for the intermediate category of glucose dysregulation that is neither diabetes nor normal. It replaces the myriad of previous terms including Pre-diabetes, impaired glucose tolerance, impaired glucose regulation, impaired fasting glucose. People in this risk category within our CCGs should be strongly advised to attend the NHS National Diabetes Prevention Programme (Healthier You) www.stopdiabetes.co.uk which is an evidenced based programme designed to reduce the risk of progression to Type 2 Diabetes. Sessions take place during the day and evenings and patients should be encouraged to attend at least the first 4 sessions which take place weekly for 4 wks. All practices should be referring to Healthier you by 1/4/18. Patients who do not wish to be referred to Healthier You can be offered a referral to Walking Away from Diabetes provided by Diabetes Care for You. This is a shorter programme but does not have an evidence base in preventing diabetes. Patients will be encouraged to go on to attend the Healthier You programme during the Walking Away session. Patients should be given lifestyle advice and CCG approved literature Patients should be counselled regarding the symptoms of Diabetes and recommended to attend for retesting if these occur. Patients who remain asymptomatic should attend annually for repeat HbA1c, Blood pressure and Lipids. Cardiovascular risk should be managed in the same way as people with Type 2 Diabetes Patients whose parameters become normal should remain coded as NDH as they will retain an increased cardiovascular risk.

What if a patient lowers their HbA1c through lifestyle change or Bariatric surgery? A US Consensus (2009) defined Diabetes remission as Partial Remission Hyperglycaemia below diagnostic thresholds (i.e. HbA1c 42-47mmol/mol, FPG 5.5-6.9mmol/l) for 1 year or more without any active diabetes pharmacological therapy or ongoing procedures Complete Remission Normal glycaemic measures (i.e. HbA1c <42mmol/mol, FPG 5.4mmol/l or less) for at least 1 year without any active diabetes pharmacological therapy or ongoing procedures Prolonged remission Complete Remission of at least 5 years duration. If Diabetes has been incorrectly coded our advice is to remove the code altogether, with a documented explanation. 'Diabetes in remission' (C10P) should be used as per 2016/17 General Medical Services (GMS) contract Quality and Outcomes Framework (QOF) Guidance for GMS contract 2016/17 (published April 2016) From April 2014 the Business Rules included a READ code for "diabetes in remission". Successful management of diabetes with lifestyle, medication, pancreatic or islet cell transplant and/or bariatric surgery may result in glucose levels falling below those diagnostic of diabetes. However these people may still experience the macrovascular and microvascular complications of diabetes and therefore need continued monitoring. Experts from the diabetes classification working group have endorsed the use of this code for people where treatment has normalised hyperglycaemia but still require continued monitoring. Patients coded 'diabetes in remission': a) are included in NDA audit b) will receive automatic invite for annual diabetes retinal screening c) need continued review for micro- and macro-vascular complications, i.e. annual diabetes review checks, and for development of hyperglycaemia. Importance of Structured education in the management of Diabetes. Referral for structured education is an essential part of the early treatment of Type 2 Diabetes and access to structured education for those with established diabetes is equally important. We would encourage colleagues to view referral to education in the same way as referral for retinal screening or annual review and to strongly encourage people with diabetes to agree to referral for DESMOND http://www.desmond-project.org.uk/newlydiagnosedandfoundationmodules-278.html

For those who are concerned about time away from work or the reaction of their employer we would encourage use of the following letter, developed with Diabetes UK. Please see recommended letter. DESMOND is a cost effective, evidence based 6 hour group education course which meets the National Quality Criteria. At present there is no approved online structured education for Diabetes that meets NHS England criteria for attendance at structured education. Please contact Diabetes Care for You if your practice needs more DESMOND patient brochures or you would like a visit from the team to discuss this. Sc-tr.sussexdiabetesenquiries@nhs.net